Cellphire Therapeutics, Inc. is a Rockville, Maryland-based biotechnology company developing next-generation therapeutics. The company is applying its proprietary cell stabilization technology to all cell types, including platelets, to develop lifesaving products. Its lead product, Thrombosomes®, a freeze-dried hemostatic agent derived from human platelets, is currently in a Phase I clinical trial. Cellphire’s technology has potential applications across a wide range of medical applications from trauma to wound care, imaging, targeted drug delivery, and regenerative medicine.
Location: United States, Maryland, Rockville
Employees: 11-50
Founded date: 2005
Investors 1
| Date | Name | Website |
| - | Circadian ... | circadian.... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 18.10.2023 | DC Money Moves: iTech AG lands its largest contract to date ... | This editorial article is a part of Biotech Month of Technical.ly’s editorial calendar. Money Moves... | technical.... |
| 02.04.2021 | Cellphire Therapeutics, Inc. Closes $15 Million Series A Fun... | ROCKVILLE, Md., April 2, 2021 /PRNewswire/ -- Cellphire Therapeutics, Inc., the global leader in l... | prnewswire... |